Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

ClinicalTrials.gov ID: NCT00294541

Public ClinicalTrials.gov record NCT00294541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 10:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study Evaluating the Long-Term Safety of ICA-17043 With or Without Hydroxyurea Therapy in Subjects With Sickle Cell Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is a follow-up companion study to Protocol ICA-17043-10, a Phase III, multi-center, efficacy and safety study of ICA-17043. This is an open-label extension study collecting safety data on the use of ICA-17043 in subjects with sickle cell disease (SCD) (e.g., HbSS, HbSC, HbSb0-thalassemia, HbSb+-thalassemia subjects). All subjects who have successfully completed ICA-17043-10 will, if deemed appropriate by their study Investigator and appropriate consent by subject is given, enroll in the ICA-17043-12 study (Study 12). Only patients who participated in ICA-17043-10 are eligible for this open label study

Study identification

NCT ID
NCT00294541
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Icagen
Industry
Enrollment
51 participants

Conditions and interventions

Eligibility (public fields only)

Age range
17 Years to 66 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2006
Primary completion
Not listed
Completion
May 31, 2007
Last update posted
Sep 10, 2007

2006 – 2007

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
28
Facility City State ZIP Site status
University of South Alabama Mobile Alabama 36617
Arkansas Children's Hospital Little Rock Arkansas 72202
Children's Hospital Oakland Oakland California 94609
University of California Davis Medical Center Sacramento California 95817
University of Colorado Health Sciences Center Denver Colorado 80262
Century Clinical Research, Inc. Holly Hill Florida 32117
University of Florida Health Science Center Jacksonville Florida 32209
Medical College of Georgia Augusta Georgia 30912
Memorial Health University Medical Center Savannah Georgia 31404
University of Illinois Medical Center Chicago Illinois 60612
Sickle Cell Center of Northern Louisiana Shreveport Louisiana 71103
Johns Hopkins University School of Medicine Baltimore Maryland 21205
Brigham and Women's Hospital Boston Massachusetts 02115
Wayne State School of Medicine Detroit Michigan 48201
University of Mississippi Medical Center Jackson Mississippi 39216
Hackensack University Medical Center Hackensack New Jersey 07601
Robert Wood Johnson Medical Center New Brunswick New Jersey 08903
Newark Beth Israel Medical Center Newark New Jersey 07112-2027
SUNY Downstate Medical Center Brooklyn New York 11203
New York Methodist Hospital Brooklyn New York 11215
University of North Carolina Hospitals Chapel Hill North Carolina 27514
Duke University Medical Center Durham North Carolina 27710
East Carolina University School of Medicine Greenville North Carolina 27858
Wake Forest University School of Medicine Winston-Salem North Carolina 27157
University of Cincinnati Cincinnati Ohio 45219
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134-1095
Medical University of South Carolina Charleston South Carolina 29425
Baylor College of Medicine Houston Texas 77030
Medical College of Virginia Richmond Virginia 23298-0157
Virginia Commonwealth University Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00294541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2007 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00294541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →